Defense (DEFN.V) tables a PEA, Goldseek (GSK.C) drops final Beschefer assays, Harfang (HAR.V) delivers Serpent results, Forum (FMC.V) plots a course for 2022

The past two weeks have been particularly brutal for investors in the junior exploration arena. High-quality stocks are being tossed with little regard for their underlying intrinsic value. At this conjuncture, year-end tax-loss selling season looms large—it seems more outrageous this year than last. If you correctly predicted this rout, and have dry powder, some […]